Tag: MDPHP risks

Methylenedioxypyrovalerone (MDPV) in the UK and Europe
Methylenedioxypyrovalerone, commonly known as MDPV, is a synthetic cathinone stimulant that first appeared in designer drug markets around 2005–2007. It gained notoriety during the late 2000s and early 2010s “bath salts” wave in the United States and parts of Europe. By 2026 MDPV has become far less common on the street in the UK and […]
MDPHP (3′,4′-Methylenedioxy-α-pyrrolidinohexiophenone) in the UK and Europe
MDPHP, chemically known as 3′,4′-methylenedioxy-α-pyrrolidinohexiophenone, is a synthetic cathinone that emerged in the European designer drug market around 2014–2015 as a successor to earlier high-risk stimulants like MDPV and α-PVP. Often sold under street names such as “monkey dust” (particularly in parts of the United Kingdom), “super speed,” or simply as an unlabeled white powder […]